Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5268900
Max Phase: Preclinical
Molecular Formula: C29H25N5OS
Molecular Weight: 491.62
Associated Items:
ID: ALA5268900
Max Phase: Preclinical
Molecular Formula: C29H25N5OS
Molecular Weight: 491.62
Associated Items:
Canonical SMILES: CCc1ccccc1-n1nc(-c2cn(Cc3ccccc3)c3ccccc23)cc1/N=C1/NC(=O)CS1
Standard InChI: InChI=1S/C29H25N5OS/c1-2-21-12-6-8-14-25(21)34-27(30-29-31-28(35)19-36-29)16-24(32-34)23-18-33(17-20-10-4-3-5-11-20)26-15-9-7-13-22(23)26/h3-16,18H,2,17,19H2,1H3,(H,30,31,35)
Standard InChI Key: JLIPYOZXPUWWJS-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 491.62 | Molecular Weight (Monoisotopic): 491.1780 | AlogP: 5.96 | #Rotatable Bonds: 6 |
Polar Surface Area: 64.21 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 7.57 | CX Basic pKa: 0.73 | CX LogP: 7.00 | CX LogD: 6.77 |
Aromatic Rings: 5 | Heavy Atoms: 36 | QED Weighted: 0.32 | Np Likeness Score: -1.19 |
1. Soni JP, Chilvery S, Sharma A, Reddy GN, Godugu C, Shankaraiah N.. (2023) Design, synthesis and in vitro cytotoxicity evaluation of indolo-pyrazoles grafted with thiazolidinone as tubulin polymerization inhibitors., 14 (3): [PMID:36970141] [10.1039/d2md00442a] |
Source(1):